CStone Pharmaceuticals (CSPHF)
USD 0.52
(0.0%)
USD 0.52
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -297.22 Million CNY | 39.52% |
| 2022 | -849.66 Million CNY | 56.96% |
| 2021 | -1.83 Billion CNY | -51.59% |
| 2020 | -1.2 Billion CNY | 22.03% |
| 2019 | -1.73 Billion CNY | -68.98% |
| 2018 | -1.02 Billion CNY | -242.4% |
| 2017 | -241.66 Million CNY | -8.21% |
| 2016 | -262.1 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q4 | -44.54 Million USD | 0.0% |
| 2023 Q2 | -32.51 Million USD | 0.0% |
| 2023 FY | - CNY | 39.52% |
| 2022 FY | - CNY | 56.96% |
| 2022 Q4 | -72.48 Million USD | 0.0% |
| 2022 Q2 | -54.22 Million USD | 0.0% |
| 2021 FY | - CNY | -51.59% |
| 2021 Q2 | -114.51 Million USD | 0.0% |
| 2021 Q4 | -165.38 Million USD | 0.0% |
| 2020 Q4 | -51.8 Million USD | 0.0% |
| 2020 Q2 | -103.37 Million USD | 0.0% |
| 2020 FY | - CNY | 22.03% |
| 2019 Q4 | -168.5 Million USD | 0.0% |
| 2019 FY | - CNY | -68.98% |
| 2019 Q2 | -80.81 Million USD | 0.0% |
| 2018 Q3 | 132.67 Million CNY | 0.0% |
| 2018 FY | - CNY | -242.4% |
| 2018 Q4 | -576.52 Million CNY | -534.54% |
| 2017 Q4 | -55.08 Million CNY | 0.0% |
| 2017 FY | - CNY | -8.21% |
| 2016 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Capstone Therapeutics Corp. | -1.74 Million USD | -16884.295% |
| Skye Bioscience, Inc. | -13.54 Million USD | -2093.939% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 416.069% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 56453.129% |
| Qrons Inc. | -40.08 Thousand USD | -741460.839% |
| Adynxx, Inc. | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.55 Million USD | -3834.855% |
| CSL Limited | 4.78 Billion USD | 106.206% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -1611.14% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -7551.918% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -31622.644% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | -437.099% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -80838.999% |
| Rebus Holdings, Inc. | -951 Thousand USD | -31153.943% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -46899.08% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -1772.904% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | -318.415% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -4913.148% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -124183.922% |
| SQZ Biotechnologies Company | -64.14 Million USD | -363.393% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -11139.586% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -19249.969% |
| Mesoblast Limited | -62.38 Million USD | -376.4% |
| Marizyme, Inc. | -34.28 Million USD | -767.014% |
| Genus plc | 73.7 Million USD | 503.29% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -4395.564% |
| Pharming Group N.V. | 9.87 Million USD | 3109.264% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -19882.695% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -8279.621% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -3288.338% |
| ContraFect Corporation | -64.99 Million USD | -357.276% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -6466.774% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -21102.975% |
| IMV Inc. | -35.52 Million USD | -736.702% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -12690.362% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -57274.249% |
| ONE Bio Corp. | 13.61 Million USD | 2283.384% |
| Accustem Sciences Inc. | -3.74 Million USD | -7833.576% |
| RVL Pharmaceuticals plc | -48.22 Million USD | -516.304% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -23356.514% |
| Q BioMed Inc. | -617.62 Thousand USD | -48023.628% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 8420.969% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -12910.568% |
| Biomind Labs Inc. | -1.03 Million USD | -28629.91% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | -649.87% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -10176.331% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -4050.448% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 4420459.905% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -1188800.0% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -11779.677% |
| GB Sciences, Inc. | -1.41 Million USD | -20833.033% |
| Alpha Cognition Inc. | -9.7 Million USD | -2962.407% |
| HST Global, Inc. | -5303.00 USD | -5604746.313% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -14349.441% |
| Halberd Corporation | -74.27 Thousand USD | -400046.744% |
| Enzolytics Inc. | -2.12 Million USD | -13906.642% |
| Agentix Corp. | -1.37 Million USD | -21567.483% |
| Resverlogix Corp. | -11.74 Million USD | -2431.298% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -9603.671% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -216.02 Million USD | -37.589% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 24522.761% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 3457.033% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -19729.462% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 78555.776% |
| AVAX Technologies, Inc. | -6.11 Million USD | -4762.463% |
| Zenith Capital Corp. | -8.6 Million USD | -3353.695% |
| Genscript Biotech Corporation | -248.71 Million USD | -19.502% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -1706030.532% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -12049.182% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -168754.47% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -15373.127% |
| Kadimastem Ltd | -2.62 Million USD | -11225.528% |
| Helix BioMedix, Inc. | -1.04 Million USD | -28306.919% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -164032.908% |
| LadRx Corporation | 412.28 Thousand USD | 72192.47% |
| Cell Source, Inc. | -4.27 Million USD | -6856.657% |
| Regen BioPharma, Inc. | 1.46 Million USD | 20375.165% |
| NovAccess Global Inc. | -1.03 Million USD | -28623.025% |
| Affymax, Inc. | -14.29 Million USD | -1979.224% |
| Itoco Inc. | -1.86 Million USD | -15802.932% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -78195.401% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -26533.065% |
| Mobile Lads Corp. | -2.24 Million USD | -13162.111% |
| CytoDyn Inc. | -18.02 Million USD | -1548.594% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -375996.117% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -2430393.09% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -61097.954% |
| SYBLEU INC | -141.57 Thousand USD | -209847.659% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -27887.025% |
| International Stem Cell Corporation | 202 Thousand USD | 147241.089% |
| Bioxytran, Inc. | -3.82 Million USD | -7680.46% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -564537.158% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -11972.835% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | -728.64% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -660400.0% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -10755.551% |
| Neutra Corp. | -181.24 Thousand USD | -163888.921% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1374.403% |
| PureTech Health plc | -11.62 Million USD | -2456.334% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | -1374.505% |
| IXICO plc | -707 Thousand USD | -41940.311% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -3767.599% |
| Gelesis Holdings, Inc. | -48.34 Million USD | -514.787% |
| CSL Limited | 4.73 Billion USD | 106.28% |
| Cellectis S.A. | -92.63 Million USD | -220.853% |